Cover - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Mar. 06, 2026 |
Jun. 30, 2025 |
|
| Cover [Abstract] | |||
| Document Type | 10-K | ||
| Document Annual Report | true | ||
| Document Period End Date | Dec. 31, 2025 | ||
| Current Fiscal Year End Date | --12-31 | ||
| Document Transition Report | false | ||
| Entity File Number | 001-34822 | ||
| Entity Registrant Name | CLEARPOINT NEURO, INC. | ||
| Entity Incorporation, State or Country Code | DE | ||
| Entity Tax Identification Number | 58-2394628 | ||
| Entity Address, Address Line One | 120 S. Sierra Ave. | ||
| Entity Address, Address Line Two | Suite 100 | ||
| Entity Address, City or Town | Solana Beach | ||
| Entity Address, State or Province | CA | ||
| Entity Address, Postal Zip Code | 92075 | ||
| City Area Code | (888) | ||
| Local Phone Number | 287-9109 | ||
| Title of 12(b) Security | Common Stock, $0.01 par value per share | ||
| Trading Symbol | CLPT | ||
| Security Exchange Name | NASDAQ | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Interactive Data Current | Yes | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | false | ||
| ICFR Auditor Attestation Flag | false | ||
| Document Financial Statement Error Correction [Flag] | false | ||
| Entity Shell Company | false | ||
| Entity Public Float | $ 328 | ||
| Entity Common Stock, Shares Outstanding | 29,663,875 | ||
| Documents Incorporated by Reference | The information required by Part III is incorporated by reference from portions of the definitive proxy statement to be filed within 120 days after December 31, 2025, pursuant to Regulation 14A under the Securities Exchange Act of 1934 in connection with the 2026 annual meeting of stockholders. |
||
| Amendment Flag | false | ||
| Document Fiscal Period Focus | FY | ||
| Document Fiscal Year Focus | 2025 | ||
| Entity Central Index Key | 0001285550 | ||
| Auditor Opinion | Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of ClearPoint Neuro, Inc. (the “Company”) as of December 31, 2025 and 2024, and the related consolidated statements of operations, stockholders’ equity, and cash flows for the years then ended, and the related notes to the consolidated financial statements. In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America. |
||
| Auditor Firm ID | 677 | ||
| Auditor Name | Cherry Bekaert LLP | ||
| Auditor Location | Tampa, Florida |